文献速递类风湿关节炎其他结缔组织病

炎症性与非炎症性风湿病对2型糖尿病临床及生物学特征的影响

Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

这项观察性多中心横断面研究纳入167例2型糖尿病患者(118例类风湿关节炎,49例骨关节炎),发现两组患者2型糖尿病均严重且代谢控制欠佳,但类风湿关节炎患者胰岛素抵抗显著高于骨关节炎患者。胰岛素抵抗与DAS28独立相关,HbA1c水平与骨侵蚀独立相关,TNF-α抑制剂治疗与胰岛素敏感性升高相关。

要点

  • 类风湿关节炎患者2型糖尿病胰岛素抵抗显著高于骨关节炎患者。
  • 胰岛素抵抗与DAS28独立相关,HbA1c与骨侵蚀独立相关。
  • TNF-α抑制剂治疗与胰岛素敏感性升高相关,低剂量糖皮质激素未显示不良关联。

核心结论

  • 类风湿关节炎患者表现为严重的2型糖尿病,并伴有炎症相关的胰岛素抵抗。

研究设计与样本

  • 观察性、多中心、横断面研究,历时24个月,连续纳入成人起病的2型糖尿病合并类风湿关节炎或骨关节炎患者,共167例(类风湿关节炎118例,骨关节炎49例)。

主要发现

  • 类风湿关节炎与骨关节炎患者均有严重2型糖尿病、代谢控制欠佳及胰岛素抵抗的生物学特征。
  • 按年龄、BMI和糖皮质激素使用分层后,类风湿关节炎患者胰岛素抵抗显著高于骨关节炎患者[HOMA2-S:63.5(35.6)vs 98.4(69.2),P < 0.001]。
  • HOMA2-S与DAS28独立相关(OR:4.46,95%CI:1.17,17.08)。
  • 2型糖尿病代谢控制与疾病活动度和功能损害无关,但HbA1c水平与骨侵蚀独立相关(OR:4.43,95%CI:1.18,16.61)。
  • 低剂量糖皮质激素治疗与胰岛素敏感性降低或HbA1c水平升高无关;TNF-α抑制剂治疗与胰岛素敏感性升高相关[101.3(58.71)vs 60.0(32.5),P = 0.001]。

临床怎么用

  • 对类风湿关节炎合并2型糖尿病患者应关注胰岛素抵抗,可考虑通过治疗关节及全身炎症来靶向胰岛素抵抗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the profile of type-2 diabetes (T2D) in patients with RA or OA. METHODS: This observational, multicentre, cross-sectional study included, over a 24-month period, consecutive patients with adult-onset diabetes and RA or OA. We collected demographics, disease activity and severity indices, current treatments for RA and diabetes, history and complications of diabetes. A systematic blood test was performed, assessing inflammatory, immunological and metabolic parameters. The homoeostasis model assessment (HOMA)2-S was used to assess insulin resistance. RESULTS: We included 167 patients with T2D, 118 with RA and 49 with OA. RA and OA patients had severe T2D with suboptimal metabolic control and a biological profile of insulin resistance. Insulin resistance was significantly higher in RA than in OA patients after stratification on age, BMI and CS use [HOMA2-S: 63.5 (35.6) vs 98.4 (69.2), P < 0.001]. HOMA2-S was independently associated with DAS28 [odds ratio (OR): 4.46, 95% CI: 1.17, 17.08]. T2D metabolic control was not related to disease activity and functional impairment, but HbA1c levels were independently associated with bone erosions (OR: 4.43, 95% CI: 1.18, 16.61). Treatment with low-dose CSs was not associated with decreased insulin sensitivity or increased HbA1c levels. Treatment with TNF-α inhibitors was associated with increased insulin sensitivity compared with patients not receiving biologics [101.3 (58.71) vs 60.0 (32.5), P = 0.001]. CONCLUSION: RA patients display severe T2D with inflammation-associated insulin resistance. These findings may have therapeutic implications, with the potential targeting of insulin resistance through the treatment of joint and systemic inflammation.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Avouac J, Elhai M, Forien M, et al. Influence of inflammatory and non-inflammatory rheumatic disorders on the clinical and biological profile of type-2 diabetes. Rheumatology (Oxford). 2021. PMID: 33458774. doi:10.1093/rheumatology/keaa810

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。